The Scylla and Charybdis of oral anticoagulant treatment

被引：55

作者：

Rosendaal, FR

机构：

来源：

NEW ENGLAND JOURNAL OF MEDICINE | 1996年 / 335卷 / 08期

关键词：

D O I：

10.1056/NEJM199608223350810

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：587 / 589

页数：3

共 17 条

[1]

ALTMAN R, 1991, J THORAC CARDIOV SUR, V101, P427

[2]

[Anonymous], 1994, Arch Intern Med

[3] OPTIMAL ORAL ANTICOAGULANT-THERAPY IN PATIENTS WITH MECHANICAL HEART-VALVES [J].

CANNEGIETER, SC ;

ROSENDAAL, FR ;

WINTZEN, AR ;

VANDERMEER, FJM ;

VANDENBROUCKE, JP ;

BRIET, E .

NEW ENGLAND JOURNAL OF MEDICINE, 1995, 333 (01) :11-17

[4]

CANNEGIETER SC, 1995, NEW ENGL J MED, V333, P1505

[5]

CORTELAZZO S, 1993, THROMB HAEMOSTASIS, V69, P316

[6] The risk for and severity of bleeding complications in elderly patients treated with warfarin [J].

Fihn, SD ;

Callahan, CM ;

Martin, DC ;

McDonell, MB ;

Henikoff, JG ;

White, RH .

ANNALS OF INTERNAL MEDICINE, 1996, 124 (11) :970-+

[7] An analysis of the lowest effective intensity of prophylactic anticoagulation for patients with nonrheumatic atrial fibrillation [J].

Hylek, EM ;

Skates, SJ ;

Sheehan, MA ;

Singer, DE .

NEW ENGLAND JOURNAL OF MEDICINE, 1996, 335 (08) :540-546

[8]

KOUDSTAAL PJ, 1995, NEW ENGL J MED, V333, P5

[9]

LAUPACIS A, 1994, ARCH INTERN MED, V154, P1449

[10]

LOELIGER EA, 1985, THROMB HAEMOSTASIS, V53, P155

← 1 2 →